Original research
by
Dunlop, Adrian J. et al
Release Date
2022
Geography
Australia
Language of Resource
English
Full Text Available
Yes
Open Access / OK to Reproduce
Yes
Peer Reviewed
Yes
Objective
This study assessed the safety of subcutaneous slow-release depot buprenorphine in custody.
Findings/Key points
This first study of depot buprenorphine in custodial settings showed treatment retention and outcomes comparable to those observed in community settings and for other opioid agonist treatment used in custodial settings, without increased risk of diversion.
Design/methods
Open-label, non-randomized trial.
Keywords
Outcomes
Legal system/law enforcement
Substitution/OAT
Diversion
